Knock-down studies of two of the factors required for Se processing that decrease after endotoxemia, selenophosphate synthetase 2 and phosphoseryl tRNA kinase, are reported to limit production of selenoproteins in vitro (25, 54). The gene discussed is SEPHS2; the disease is serum lipopolysaccharide activity.